# Combined Effects of Bioactive Compounds in Lipid Profile

> **NCT01562080** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rottapharm Spain** · enrollment: 118 (actual)

## Conditions studied

- Hyperlipidemia
- Low-density-lipoprotein-type
- Elevated Triglycerides

## Interventions

- **DIETARY_SUPPLEMENT:** Armolipid Plus
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT01562080
- **Lead sponsor:** Rottapharm Spain
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-10
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2013-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562080, "Combined Effects of Bioactive Compounds in Lipid Profile". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01562080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*